Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics (TSXV:EMH) (OTC:EMHTF) (FRA:TBD)
EMH
EMHTF
TBD

Emerald Health Therapeutics Inc. (TSXV:EMH) (OTC:EMHTF) (FRA:TBD) is licensed in Canada to produce and sell dried cannabis and cannabis oil for medical purposes. Emerald is preparing to serve the fully legalized Canadian adult-use cannabis market starting October 17, 2018. Emerald owns 50% of Pure Sunfarms, which is converting a licensed existing 1.1 million square foot greenhouse in Delta, BC and is now in commercial production. It owns Agro-Biotech, a QuΓ©bec-based licensed cannabis grower with a 75,000 square foot indoor facility and is planning to add a 500,000 square foot greenhouse in Metro Vancouver. Emerald’s team is highly experienced in life sciences, product development, large-scale agri-business, and marketing, and is focused on developing value-added cannabis-based products with potential wellness and medical benefits. Emerald is part of theΒ Emerald Health group, which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.

Canada

Ratings

There are no reviews yet.

Post your review

Directions to listing

Send Message to listing owner

Emerald Health Therapeutics, Inc.